Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS) - PubMed (original) (raw)
. 2011 Nov-Dec;21(6):930-7.
doi: 10.1684/ejd.2011.1550.
Affiliations
- PMID: 21951554
- DOI: 10.1684/ejd.2011.1550
Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS)
Chia-Hung Wei et al. Eur J Dermatol. 2011 Nov-Dec.
Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous drug reaction. Although the severity-of-illness score (SCORTEN) has been proposed for toxic epidermal necrolysis (TEN) for 10 years, a prognostic score for DRESS is still lacking. To identify prognostic factors of DRESS patients during hospitalization in one medical health system in Taiwan. We retrospectively reviewed all patients with DRESS diagnosed by dermatologists in Chang Gung Memorial Hospital (CMGH) Health System from 2001 to 2010. To study prognostic factors, we collected data at early disease and maximal disease stages. 91 individuals, including 13 dead patients, were evaluated. Five independent prognostic factors of death were found: heart rate > 90/min, white blood cells >12,000/mm(3) and respiratory rate >20/min (at early disease stage), coagulopathy and gastrointestinal bleeding (at maximal disease stage). In addition, systemic inflammatory response syndrome (SIRS) occurred at a much higher percentage among non-survivors throughout hospitalization. We found tachycardia, leukocytosis, tachypnea, coagulopathy, gastrointestinal bleeding and SIRS were associated with a poor outcome in DRESS patients. DRESS patients with persistent SIRS during hospitalization were also associated with a higher mortality risk. Early recognition and prompt intervention in these factors may improve outcome.
Similar articles
- Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.
Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, Hu S, Hong HS, Chung WH. Chiou CC, et al. J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1044-9. doi: 10.1111/j.1468-3083.2008.02585.x. Epub 2008 Jul 4. J Eur Acad Dermatol Venereol. 2008. PMID: 18627428 - Clinical features and prognostic factors in severe cutaneous drug reactions.
Yang MS, Kang MG, Jung JW, Song WJ, Kang HR, Cho SH, Min KU. Yang MS, et al. Int Arch Allergy Immunol. 2013;162(4):346-54. doi: 10.1159/000354918. Epub 2013 Oct 25. Int Arch Allergy Immunol. 2013. PMID: 24193402 - Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
Walsh S, Diaz-Cano S, Higgins E, Morris-Jones R, Bashir S, Bernal W, Creamer D. Walsh S, et al. Br J Dermatol. 2013 Feb;168(2):391-401. doi: 10.1111/bjd.12081. Br J Dermatol. 2013. PMID: 23034060 - Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.
Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, Hristakieva E, Tzaneva V. Ganeva M, et al. Int J Dermatol. 2008 Aug;47(8):853-60. doi: 10.1111/j.1365-4632.2008.03637.x. Int J Dermatol. 2008. PMID: 18717872 Review. - The DRESS syndrome: a literature review.
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. Cacoub P, et al. Am J Med. 2011 Jul;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017. Epub 2011 May 17. Am J Med. 2011. PMID: 21592453 Review.
Cited by
- Severe cutaneous adverse reactions in a tertiary care center in Jamaica.
McNish AJS, Ho JD, East-Innis ADC. McNish AJS, et al. JAAD Int. 2024 Feb 19;15:139-146. doi: 10.1016/j.jdin.2024.02.007. eCollection 2024 Jun. JAAD Int. 2024. PMID: 38545494 Free PMC article. - DRESS and Stevens-Johnson Syndrome Overlap Secondary to Allopurinol in a 50-Year-Old Man-A Diagnostic and Treatment Challenge: Case Report.
Martínez JD, Franco R, Sáenz LM, Alvarado AG, García JA, Delgado SM, Ionescu MA, Busilă C, Tatu AL. Martínez JD, et al. Life (Basel). 2023 Nov 24;13(12):2251. doi: 10.3390/life13122251. Life (Basel). 2023. PMID: 38137852 Free PMC article. - Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.
Chen CB, Hung WK, Wang CW, Lee CC, Hung SI, Chung WH. Chen CB, et al. Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37457584 Free PMC article. Review. - Predicting antipsychotic-induced weight gain in first episode psychosis - A field-wide systematic review and meta-analysis of non-genetic prognostic factors.
Fitzgerald I, Sahm LJ, Byrne A, O'Connell J, Ensor J, Ní Dhubhlaing C, O'Dwyer S, Crowley EK. Fitzgerald I, et al. Eur Psychiatry. 2023 Jun 6;66(1):e42. doi: 10.1192/j.eurpsy.2023.2417. Eur Psychiatry. 2023. PMID: 37278237 Free PMC article. Review. - Current Perspectives on Severe Drug Eruption.
Zhang J, Lei Z, Xu C, Zhao J, Kang X. Zhang J, et al. Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17. Clin Rev Allergy Immunol. 2021. PMID: 34273058 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical